Compare FMS & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FMS | GMED |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.2B | 12.9B |
| IPO Year | N/A | 2012 |
| Metric | FMS | GMED |
|---|---|---|
| Price | $23.05 | $85.58 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $30.00 | ★ $100.42 |
| AVG Volume (30 Days) | 540.0K | ★ 984.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.48% | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 3.92 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.11 | $6.45 |
| P/E Ratio | ★ $15.62 | $21.82 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $20.96 | $51.79 |
| 52 Week High | $30.46 | $101.40 |
| Indicator | FMS | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 39.18 |
| Support Level | $22.50 | $57.74 |
| Resistance Level | $24.08 | $87.16 |
| Average True Range (ATR) | 0.38 | 2.68 |
| MACD | -0.08 | -0.81 |
| Stochastic Oscillator | 54.27 | 8.51 |
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.